Drug Search Results
More Filters [+]

HS-10398

Alternative Names: HS-10398, HS 10398, HS10398
Latest Update: 2024-04-25
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Jiangsu Hansoh
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for HS-10398

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

HS-10398-101

P1

Not yet recruiting

Healthy Volunteers

2025-01-31

28%

Recent News Events

Date

Type

Title